sur MedMira, Inc. (CVE:MIR)
MedMira and Lovell Partner to Expand Distribution of Reveal® G4 HIV Test
MedMira Inc. has announced a partnership with Lovell Government Services to improve access to its Reveal® G4 HIV-1/2 rapid test across federal healthcare systems. The partnership targets the Veterans Health Administration, Military Health System, and Indian Health Service. Lovell will serve as MedMira's Service-Disabled Veteran-Owned Small Business vendor through federal contracts.
The Reveal® G4 HIV test is recognized for its speed and accuracy, built on MedMira's Rapid Vertical Flow Technology. It is designed to deliver immediate results without fading, avoiding issues like false negatives due to the prozone effect, common in traditional tests. It is available in three formats suitable for various healthcare settings.
Products are accessible through the Department of Veterans Affairs' Federal Supply Schedule, GSA Advantage, and the Department of Defense's contract vehicles, facilitating streamlined procurement processes.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de MedMira, Inc.